Journal of Oriental Neuropsychiatry (동의신경정신과학회지)

The Korean Society of Oriental Neuropsychiatry (대한한방신경정신과학회)
권호 표지

The Effects of Sahyangsohapwon on the Affective Reactivity and the Acquisition of Two-way avoidance in AD Model Rats

사향소합원(麝香蘇合元)이 정서반응성(情緖反應性)과 Alzheimer's disease 모델 백서(白鼠)의 학습(學習)에 미치는 영향(影響)

  • Hong Dae-Sung (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University) ;
  • Kim Jong-Woo (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University) ;
  • Whang Wei-Wan (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University)
  • 홍대성 (경희대학교 한의과대학 신경정신과 교실) ;
  • 김종우 (경희대학교 한의과대학 신경정신과 교실) ;
  • 황의완 (경희대학교 한의과대학 신경정신과 교실)
  • Published : 1999.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

The effects of Sahyangsohapwon on the affective reactivity of rats were studied with open-field behavior. Sample group was treated with the medicine for 8 weeks, whereas control group was treated with the vehicle. The effects of Sahyangsohapwon on the enhancement of learning and memory of AD model rats were studied with two-way avoidance task. Sample group electrically lesioned on nbM(nucleus basalis of Meynert) was treated with the medicine for 8 weeks, whereas control group with nbM lesion and sham group with the sham operation were treated with the vehicle. 1. In the open-field behavior task, the start latency from start box was measured $27.08{\pm}7.51sec$ in control group, $23.15{\pm}5.98sec$ in sample group. Rats in sample group showed a tendency of shortened latency going out to a strange place compared with those in control group, but with no statistical significance(p>0.05). 2. In the open-field behavior task, the number of locomotion crossing the grid lines was measured $84.54{\pm}3.55$ in control group, $116.93{\pm}6.41$ in sample group. There was an increased locomotion in sample group compared with control group with statistical significance(p<0.01). This can be interpreted as rats in sample group showed lowerd anxiety under a strange environment. 3. In the open-field behavior task, the rearing number was measured $7.46{\pm}0.57$ in control group, $10.13{\pm}0.95$ in sample group. There was an increased rearing in sample group compared with control group with statistical significance(p<0.05). This can also be interpreted as rats in sample group showed lowerd anxiety under a strange environment. 4. In the open-field behavior task, the number of crossing behavior was measured $5.54{\pm}1.50$ in control group, $9.20{\pm}1.67$ in sample group. There was a increasing tendency of crossing behavior in sample group compared with control group, but with no statistical significance(p<0.05). 5. In the open-field behavior task, the total activity was measured $97.54{\pm}4.70$ in control group, $136.27{\pm}792$ in sample group. There was an increased total activity in sample group compared with control group with statistical significance(p<0.01). This can also be interpreted as rats in sample group showed lowerd anxiety under a strange environment. 6. In the analysis of effects on the learning and memory in AD model rats with two-way avoidance task, the response latency was measured $6717{\pm}134msec$ in the 1st session, $5416{\pm}160msec$ in the 2nd session, $5252{\pm}148msec$ in the 3rd session in control group. It was measured $6724{\pm}155msec$ in the 1st session, $4642{\pm}139msec$ in the 2nd session, $4914{\pm}148msec$ in the 3rd session in sample group and $4357{\pm}144msec$ in the 1st session, $3125{\pm}115msec$ in the 2nd session, $3091{\pm}98msec$ in the 3rd session in sham group. There were differences between sham group and nbM lesioned groups with statistical significance in post hoc analysis(p<0.000). And in the 2nd session, there was a reduction of latency in sample group compared with control group with statistical significance (p<0.000). This showed that sample group had better learning capacity than control group. 7. In the analysis of effects on the learning and memory in AD model rats with two-way avoidance task, the number of avoidance response was measured $5.85{\pm}1.41$ in the 1st session, $14.23{\pm}2.89$ in the 2nd session, $15.69{\pm}2.56$ in the 3rd session in control group. It was measured $7.92{\pm}1.94$ in the 1st session, $16.83{\pm}2.29$ in the 2nd session, $15.42{\pm}2.81$ in the 3rd session in sample group and $14.38{\pm}1.62$ in the 1st session, $22.88{\pm}0.89$ in the 2nd session, $23.88{\pm}1.64$ in the 3rd session in sham group. There were differences between sham group and nbM lesioned groups with statistical significance in post hoc analysis(p<0.001). But between control and sample group, there was no significant difference. With the experimental results above, Sahyangsohapwon can be supposed to have the enhancing effects on the affect reactivity and learning with memory of AD model rats induced by electrolyte injury of nbM.

Keywords

References

  1. 韓方製劑解說集(2集) 麗熙醫療院 韓方病院
  2. 方證新編 宋炳基
  3. 方藥合編解說 申載鏞
  4. 韓醫學硏究所論文集 痴매의 治療에 關한 東西醫學的 考察 李東垣(外)
  5. 東醫寶鑑 計俊
  6. 精校黃帝內經靈樞 洪元植(編)
  7. 精校黃帝內經素問 洪元植(編)
  8. 신경정신의학 v.29 no.6 Mattis Dementia Rating Scale (MDRS)의 非痴매 老人群에 對한 硏究 곽호순(외 2인)
  9. 大韓精神藥物學會誌 v.2 no.1 Alzheimer씨 痴매一槪論 및 最新 傾向- 김진수
  10. 가정의학회지 v.18 no.3 痴매(dementia)의 接近 方法 나덕렬
  11. 대한신경과학회지 v.3 no.1 神經科 領域에서의 痴매 박영춘
  12. 신경정신의학 v.33 no.2 Alzheimer型 痴매 疑心과 輕度 Alzheimer型 痴매의 認知機能 比較 박종한
  13. 신경정신의학 v.32 no.1 地域祉會의 痴매 有病率 조사에서 선별검사(Screening Test)의 의의 박종한
  14. 대한정신약물학회지 v.3 no.1 痴매의 原因과 治療 박종한
  15. 신경정신의학 v.34 no.3 Alzheimer型 痴매 疑心의 認知機能 박종한(외 3인)
  16. 신경정신의학 v.30 no.5 경북 영일군 어느 면지역 노인들에서의 痴매의 原因的 分類 및 主要 痴매의 相對的 有病率 박종한;고효진
  17. 大韓韓醫學會誌 v.23 no.2 老人性 痴매에 關한 體質醫學的 硏究 裵旿星
  18. 四關穴訓針刺와 麝香蘇合元이 鎭痛 抗痙攣 抗瀉下 血淸成分 變化 및 胃機能에 미치는 影響 安榮基
  19. 대한정신약물학회지 v.7 no.2 노인정신장애의 치료-인지장애 Alzheimer형 痴매患者의 藥物治療를 중심으로 오병훈
  20. 서울대학교 병원 대형 공동과제 연구 보고서 한국 노인인구의 痴매의 역학적 특성에 관한 연구 우종인(외 3인)
  21. 麝香蘇合元이 再灌流裝置下의 흰쥐 心臟에미치는 影響 李英彬
  22. 大韓韓方內科學會紙 v.13 no.2 老人性 痴매에 對한 文獻的 考察 李源哲(外2人)
  23. 대한의학협회지 v.37 no.7 老人性 痴매; 역학-유병률 및 위험요인 이정희
  24. 慶熙醫學 v.13 no.1 痴매 장대일
  25. 동의신경과학회지 v.7 no.1 痴매에 對한 文獻約 考察 鄭仁哲;李相龍
  26. 荊防地黃湯이 AD모델 白鼠의 學習과 記憶에미치는 影響 趙潤淑
  27. 경희의학 v.13 no.1 痴매의 자기공명영상 진단 최우석
  28. 신경정신의학 v.34 no.3 痴매患者에서의 한국어판 노인용 간호사 관촬척도의 타당도와 신뢰도 검증을 위한 예비적 연구 채정호(외 5인)
  29. 蘇合香元이 實驗的 腦梗塞 흰쥐의 局所腦血流量 및 梗塞 面積에 미치는 影響 崔恩禎
  30. 慶熙醫學 v.12 no.2 痴매에 關한 韓醫學的 臨床 硏究 黃義完(外 4人)
  31. 慶熙醫學 v.13 no.1 痴매治療에 對한 韓醫學的 接近方法 黃義完
  32. 萬病回春 공廷賢
  33. 壽世保元 공廷賢
  34. 中藥學講義 成都中醫學院(編)
  35. 中草藥學 上海中醫學院(編)
  36. 景岳全書 張景岳
  37. 金궤鉤玄 朱震亨
  38. 東醫臨床要覽 金定濟;金賢濟
  39. 神經精神科學 大韓神經精神醫學會
  40. 보건사회통계연보 no.36 보건복지부
  41. 보건사회백서 보건사회부
  42. 노인병학 성인병 서순규
  43. 神經傳達物質 徐維憲
  44. 東醫臨床方劑學 尹吉榮
  45. 노인생활실태 분석 및 정책과제 이가옥(외)
  46. 本草學 李尙仁
  47. 漢藥臨床應用 李尙仁(外 2人)
  48. 精神醫學 李定均
  49. 한국통계연감 no.38 통계청
  50. 東醫精神醫學 黃義完;金知赫
  51. 계명의대논문집 v.16 no.3 Azheimer병의 진단적 평가 김도관;노주선
  52. 蘇合香元이 白鼠의 腦損傷에 미치는 影響 金淳信
  53. 經熙醫學 v.6 no.4 蘇合香元의 抗心理的 스트레스 效果에 關한 實驗的 硏究 金知赫;黃義完
  54. 대한신경과학회지 v.3 no.1 Alzheimer's disease의 신경화학적 변화에 對한 고찰 김진수
  55. 牛黃淸心元과 蘇合香元의 效能에 關한 硏究 南相璟
  56. 韓國心理學會誌 :生物 및 生理 v.7 no.1 Capsaicin이 成熟한 횐쥐피 痛覺反應과 open-field 行動에 미치는 影響 박순권(외 3인)
  57. 신경정신의학 no.2 노인기능상태 평가의 신뢰도 박종한(외 2인)
  58. 계명의대논문집 v.16 no.3 老化에 관련된 인지기능 감퇴 박종한;김희철
  59. 신경정신의학 v.29 no.4 老人集團에서 한국판 Miili-Mental State Examination의 진단능력 박종한;고효진
  60. 신경정신의학 v.29 no.2 Down症候群과 Alzheimer病의 關係 박종한;전철호
  61. 계명의대 논문집 v.16 no.3 Alzheimer병의 신경병리학적 소견과 분자생물학적 연구동향 손윤경
  62. 신경정신의학 v.34 no.3 노인정신장애환자의 추적치료 실태에 대한 고찰 신명기(외 2인)
  63. 신경정신의학 v.28 no.3 노인의 정신장애에 관한 역학적 硏究( I )-硏究設計- 신승철(외 3인)
  64. 계명의대논문집 v.16 no.3 Alzheimer병 연병길;박종한
  65. 계명의대논문집 v.16 no.3 Alzheimer病의 精神社會的 治療 오병훈
  66. 신경정신의학 v.35 no.6 알츠하이머병의 말초 생물학적 지표로서 혈청 Alpha-1-anti chymo trypsin 우종인(외 2인)
  67. 신경정신의학 v.36 no.1 한국의 한 농촌 지역에 거주하는 노인에서의 치매의 유병률 우종인(외 6인)
  68. 대한정신약물학회지 v.7 no.2 노인 정신병의 藥物治療 윤도준
  69. 調胃升淸湯이 AD모델 白鼠의 學習과 記憶에 미치는 영향 李雄錫
  70. 대한정신약물학회지 v.8 no.1 에스트로젠과 알쯔하이머병 이종섭;김찬형
  71. 少陰人 蘇合香元의 效能에 關한 實驗的 硏究 全震相
  72. 證治準繩 王肯堂
  73. 中醫養生學 劉占文
  74. 醫宗必讀 李中梓
  75. 醫學入門(全五卷中二) 李挺
  76. 辨證奇問全書 錢鏡湖
  77. 太平患民和劑局方 v.3 陳師文
  78. 石室秘錄(下) 陳士澤
  79. 實用中醫內科學 黃大東(外)
  80. Behavioral Brain Research The efficacy of response prevention on avoidance behavior in young and adult rats with prefrontal cortical injury Brennan, J.F.;Wisniewski, C.
  81. Phamacological treatment of Alzheimer’s Disease Brioni, J.D.(et al)
  82. Pathophysiology;adaptation and alterations infunctions 4th edition Bullock, B.L.
  83. Specialized Dementia Care Units Coons, D.H.
  84. Harrison’s Principles of Internal Medicine 11th edition Eugene, B.(et al)
  85. Progress in Alzheimer’s disease and similar conditions Heston, L.L.
  86. Physiol Behav Effects of nucleus basolateralis amygdalae neurotoxic lesions on aversive conditioning in the rat Lorenzini, C.A.(et al)
  87. Experimental therapeutics, cholinesterase inhibitors, Psychophamacology : the 4th generation of progress Marin, D.B.(et al)
  88. Medical Neurology 3rd edition Meyer, J.S.
  89. Brain Research Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks Miyamoto, M.(et al)
  90. J Neurose Res Nicotinic and muscarinic subtypes in the human brain : Changes with aging and dementia Nordberg, A.(et al)
  91. The rat brain in stereotaxic coordinates Paxinos, G. Watson
  92. Atlas of clinical neurology 2nd edition Perkin, G.D.;Hochberg, F.H.
  93. Do psychosocial risk factors contribute to Alzheimer’s disease? In Etiology of Dementia of Alzheimer Type Mortimer, J.A.
  94. Merritt’s Textbook of Neurology 7th edition Rowland, L.P.
  95. Brain Reserch Effects of dopamine depletion in the medial prefrontal cortex on active avoidance and escape in the rat Sokolowski, J.D.(et al)
  96. Brain cholinergic systems Steriade, M;Bidlsold, D.
  97. Clinical Neurology Swash, M.;Oxbury, J.
  98. Brain Research Bulletin The early acquisition of two-way avoidance as an anxiety-Mediated behavior Teruel, A.F.(et al)
  99. Cecil Textboox of Medicine 17th edition Wyngaarden, J.B.(et al)
  100. Biomed Phamacother v.48 no.7 Alzheimer’s disease:rhythm, timing and music as therapy Aldridge, D.
  101. Bull Acad Natl Med v.180 no.7 Risk factors of Alzheimer’s disease, Epidemiologic approach Alperovitch, A.;Berr, C.
  102. Brain Res v.674 no.2 Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21 Arendash, G.W.(et al)
  103. J Altem Complement Med v.3 no.4 Effects of Trasina,an-ayur-vedic herbal formulation, on experimental models of Alzheimer’s disease and central cholinergic markers in rats Bhattacharya, S.K.;Kumar, A.
  104. J Pharmacol Exp Ther v.277 no.2 Pharmacological evaluation of novel Alzheimer’s disease therapeutics;acetylcho linesterase inhibitors related to galanthamine Bores, G.M.(et al)
  105. Br J Clin Psychol v.36 Single case evaluation of the effects of aroma therapy and massage on disturbed behaviour in severe dementia Brooker, D.J.(at al)
  106. Arch Neurol v.53 no.2 Relationship of age, education and occupation with dementia among a community-based sample of African Americans Callahan, C.M.(et al)
  107. Psychopharmacology v.214 no.4 Alpha 2-adrenoceptor antagonists potentiate acetycholin-esterase inhibitor effects on passive avoidance learning in the rat Camacho, F.(et al)
  108. Am J Occup Ther v.48 no.10 The effect of music on repetitive disruptive vocalizations of persons with dementia Casby, J.A.;Holm, M.B.
  109. Neurology v.50 no.4 Prevalence of dementia in Chinese elderly in Hong Kong Chiu, H.F.(et al)
  110. Neurology v.47 Neuropsychiatric aspects of Alzheimer’s disease Cumming, J.I.(et al)
  111. Science v.247 The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity Weiss, J.H.(et al)
  112. Am J Public Health v.77 The public health impact of Alzheimer’s disease Weiler, P.G.
  113. J Neurol Sci v.147 no.1 Autosomal dominant early onset dementia and leukoencephalopathy in a Japanese faily;clinical, neuro-imaging and genetic studies Utausu, Y.(et al)
  114. Nippon Koshu Eisei Zasshi v.44 no.9 Intakes and health effects of aluminum.” Is aluminum a risk factor for Alzheimer’s disease?.” Uchida, H.;Nagai, M.
  115. Bull Exp Biol Med v.123 no.3 Postnatal stress impairs the learning of two-way avoidance task in prenatally alcoholized adult rats Trofimov, S.S.(et al)
  116. Biol Psychiatry v.27 Short-term effects of the calcium channel blccker nimodipine Bay-e 9736 in the management of primary degenerative dementia Tollefsen, G.D.
  117. Neurobiol Aging v.16 no.5 Nicotine enhances Morris water maze performance of young and aged rats Socci, D.J.(et al)
  118. J Phamacol Exp Ther v.280 no.2 Pharmacological activity and safely profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer’s disease Smith, C.P.(et al)
  119. Acta Psychiatrica Scandinavica v.74 Prevalence of dementia in a Japanese elderly population Shibayama, H.(et al)
  120. Neurochem Int v.30 no.2 Systemic administration of defined extracts from Withania somnifera(Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABA-ergic markers in rat brain Schliebs, R.(et al)
  121. Behav Brain Res v.67 no.2 Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer’s disease Scherder, E.J.(et al)
  122. Neuroepidemiology v.16 no.1 Cognitive predictors of dementia in elderly community residents Dartigues, J.F.(et al)
  123. J Med Chem v.38 no.18 Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydro-quinolinones as potential agents for the treatment of Alzheimer’s disease Fink, D.M.(et al)
  124. Can J Psychiatry v.26 Double blind study of lecithin in patients with Alzheimer’s disease Fisman, M.(et al)
  125. Behav Brain Res v.83 no.1;2 Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats Fujiwara, M.(et al)
  126. Jpn J pharmacol v.74 no.3 From molecular structure to Alzheimer therapy Giacobini, E.
  127. Neurotoxicology v.17 no.2 Neurotoxicity induced by prenatal aluminum exposure in rats Gonda, Z.(et al)
  128. Alcohol v.11 no.3 Alcohol and the brain;setting the benefit/risk balance Govoni, S.(et al)
  129. Behav Brain Res v.73 no.1;2 Serotonergic regulation of associative learning Harvey, J.A.
  130. Neurobiol Aging v.19 no.1 How to cope with Alzheimer’s disease? Hasegawa, K.
  131. Nihon Shinkei Seishin Yakurigaku Zasshi v.18 no.2 Recent advances in Alzheimer’s disease research Hirai, S.
  132. Am J Chin Med v.24 no.3;4 Regulatory effect of dangui-shaoyao-san on central cholinergic nervous system dysfunction in mice Itoh, T.(et al)
  133. Acta Neurol Scand v.69 Cerebrospinal fluide parameters in Alzheimer’s disease during org2766 treatment Jolkkonen, J.T.(et al)
  134. N Eng J Med v.314 Alzheimer’s disease Katzman, R.
  135. FASEB J v.5 Advances in Alzheimer’s disease Katzman, R.;Saitoh, T.
  136. Int Psychogeriatr v.7 no.3 Prevalence of dementia among elderly Chinese and Malay residents of Singapore Kua, E.H.;Ko, S.M.
  137. Phamacol Biochem Behav v.51 no.2;3 Effects of nicotinic dimethy laminoethyl esters on working memory performance of rats in the radial-arm maze Levin, E.D.(et al)
  138. Acta Psychiatrica Scandinavica v.79 An epidemiological survey of agerelated dementia in an urban area of Beijing Li, G.(et al)
  139. Brain Res v.706 no.2 Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction Maurice, T.(et al)
  140. Neurology v.47 Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease, a review of 17 epidemiologic studies McGeer, G.(et al)
  141. Neurology v.34 Clinical diagnosis of Alzheimer’s disease;report of the NINCDSADRDA work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer’s disease McKhann, G.(et al)
  142. J Pharmacol Exp Ther v.277 no.3 Effects of 3-[1-(phenymethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1-H-1-benzazepin-8-yl)-1-propanone fumarate(TAK-147), a novel acetylcholineesterase inhibitor on impaired learning and memory in animal models Miyamoto, M.(et al)
  143. Nippop Renen Igakkai Zasshi v.34 no.2 Dementia-causes, diagnosis, treatment, and care Morimatsu, M.
  144. Effects of dietary phosphatidylcholine on memory in memory deficient mice with low brain acetylcholine concentration v.58 no.6 Moriyama, T.(et al)
  145. Acta Psychiatrica Scandinavica v.79 The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination O’Connor, D.W.(et al)
  146. Acupunct Electrother Res v.17 no.2 Common factors contributing to intractable pain and medical problems with insufficient drug uptake in areas to be treated, and their pathogenesis and treatment Omura, Y.(et al)
  147. Am J Epidemiol v.140 Estrogen deficiency increase the risk of Alzheimer’s disease in woman Paganini-Hill, A.;Henderson, V.W.
  148. British of Journal Psychiatry v.164 no.6 Demetia among the elderly in a rural Korean community Park, J.(et al)
  149. The brain in order persons with and without dementia, finding on MR, PET, and SPECT image, AJR v.162 Patrica, C.D.(et al)
  150. Neurobiol Aging v.7 Desamion-D-arginin-vaso-pressin in Alzheimer’s disease Peabody, C.A.(et al)
  151. Int J N eurosci v.90 no.1 Effects of Physostigmine and Verapamil on Active Avoidance in an Experimental Model of Alzheimer’s disease Popovic, M.(et al)
  152. Can Fam Physician v.44 Does ginkgo help delay dementia? Por, C.P.(et al)
  153. Neurology v.33 vasopressin in Alzheimer’s disease Reding, M.J.(et al)
  154. Pharmacol Toxicol v.79 no.3 Effects of perinatal lead exposure on rat behaviour in open-fild and two-way avoidance tasks Rodriques, A.L.(et al)
  155. the efficacy and safety of Donepezil in patients with Alzheimer’s disease-results of a US multicenter randomized, double-blind, placebo-controlled tral, Dementia v.7 Rogers, S.L.(et al)
  156. The Journal of Family Practice v.37 no.6 Advances in Alzheimer’s disease Roth, M.E.
  157. Tijdschr Gerontol Geriatr v.28 no.2 Peripheral nerve stimulation in Alzheimer’s disease Scherder, E.J.(et al)
  158. Biol Psychiatry v.43 no.6 Effects of “isolated” transcutaneous electrical nerve stimulation on memory and affective behavior in patients with probable Alzheimer’s disease Scherder, E.J.(et al)